Pharma Manufacturing

Menu

Newsletters
Subscribe

Newsletters
Subscribe

Follow us on:

Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sector

Home|
Solution Providers|
E-News|
Subscribe|
Resource Directory|
Webinars|
Current Issue

Follow us on:

On Pharma

Biogen IDEC Up for Sale: Carl Icahn Interested

Category: The Pharma Industry Biotechnology and biopharmaceuticals

Submitted by pharmamanufacturing on Fri, 10/12/2007 - 18:07

http://www.reuters.com/article/marketsNews/idUSWEN165220071012

Permalink

Show Comments

Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments

Most Popular

Past 7 Days
Past 30 Days
Past 6 Months

01

Pfizer recalls migraine drug for possible microbial contamination

Pfizer has recalled two lots of migraine drug Relpax after finding those…
02

AbbVie’s Humira follow-up gets FDA nod

A potential new blockbuster from AbbVie has gotten the go-ahead from the…
03

FDA rejects potential jet lag treatment

Vanda Pharmaceuticals announced that it has received a complete response…
04

FDA warns Chinese company for drug manufacturing data integrity violations

The organization sent Ningbo Huize Commodity a warning letter for…
05

Celgene wins key FDA ok ahead of BMS merger

The U.S. FDA has approved Celgene's rare bone marrow cancer drug, Inrebic,…

01

FDA says Novartis gene therapy drug application contains manipulated data

On May 24, the FDA approved Zolgensma, a gene therapy product intended to…
02

What’s behind all the M&A deals in pharma?

As far as M&A deals go, 2019 has started off with a boom.
03

2019 Pharma Innovation Awards

This year's winners offer slices of innovation
04

Top Novartis scientists exited company ahead of data scandal

More details are emerging about the months leading up to Novartis’s…
05

States probe Eli Lilly over insulin prices

Eli Lilly has been hit with a subpoena from the New York Attorney…

01

Merck to cut jobs, close plants with $1.2B restructuring plan

Merck and Co. has created a restructuring plan it says is designed to…
02

The Highest — and Lowest — Ranked Places to Work in Big Pharma

How pharma companies fair on Glassdoor.
03

Torrent hit with Form 483

The FDA found that in hundreds of cases, batches at Torrent’s plant did…
04

Anti-vaxxers turn to potatoes

A new and weird rumor has surfaced in the anti-vaccine movement: potatoes…
05

FDA says Novartis gene therapy drug application contains manipulated data

On May 24, the FDA approved Zolgensma, a gene therapy product intended to…

Pharma Manufacturing

About

General Information
Contact Us
Subscription Services
Media Kit
Editorial Calendar
Editorial Submissions Guidelines
Editorial Advisory Board

Content

Resource Libraries
OpEd
Fundamentals
News
Articles
White Papers
Products
All Star Innovators
Funny Pharm

Magazine

Subscribe (print)
Current Issue
Issue Archive

Site Tools

Site Map
Resource Directory

Stay Connected

My Account
Events Calendar
E-Newsletters
Human Interest
Facebook
Twitter
LinkedIn
YouTube
RSS Feed

Contact Us | Advertise | Privacy Policy | Legal Disclaimers, Terms & Conditions

Copyright © 2004 - 2019 Pharma Manufacturing. All rights reserved.

P: 630-467-1300 | 1501 E. Woodfield Road, Suite 400N, Schaumburg, IL 60173

Chemical Processing | Control | Control Design | Food Processing | Pharma Manufacturing | Plant Services | Smart Industry